PARSHALL B LYNNE — SEC insider filings
SEC reporting owner CIK 1073385. 51 insider filings on record with FilingPulse; latest filed 2026-11-12.
Transaction summary — filings shown
Covers the 50 most recent of 51 filings on record, filed 2020-10-13 to 2026-11-12. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.
- Open-market purchases (code P, non-derivative): none reported.
- Open-market sales (code S, non-derivative): 37 legs across 26 filings — 321,762 shares, $16,778,920 total (shares × price as filed).
- Other reported legs (grants, option exercises, tax withholding, gifts, derivative-security transactions, …): 98.
- Largest priced transaction: sale of 50,000 shares @ $50.23 ($2,511,515) in IONIS PHARMACEUTICALS INC, filed 2023-12-28.
By issuer — same filings
Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.
| Issuer | Role (as filed) | Filings | Purchases (P) | Sales (S) | Other legs |
|---|---|---|---|---|---|
| IONIS PHARMACEUTICALS INC (IONS) | Director | 22 | — | 16 legs · 185,138 sh · $9,747,163 | 46 |
| CYTOKINETICS INC (CYTK) | Director | 22 | — | 21 legs · 136,624 sh · $7,031,758 | 46 |
| Foghorn Therapeutics Inc. (FHTX) | Director | 5 | — | — | 5 |
| AKCEA THERAPEUTICS, INC. (AKCA) | Director | 1 | — | — | 1 |
Insider filings — PARSHALL B LYNNE
| Filed | Form | Issuer | Reported transactions | Source |
|---|---|---|---|---|
| 2026-11-12 | 4 | CYTOKINETICS INC (CYTK) | Sale (S): 2,445 @ $54.17 · Sale (S): 2,555 @ $55.26 | EDGAR |
| 2026-09-01 | 4 | CYTOKINETICS INC (CYTK) | Sale (S): 5,000 @ $71.48 | EDGAR |
| 2026-06-25 | 4 | Foghorn Therapeutics Inc. (FHTX) | Grant/award (A): 28,000 (derivative) @ $4.08 | EDGAR |
| 2026-06-01 | 4 | CYTOKINETICS INC (CYTK) | Sale (S): 5,000 @ $74.08 | EDGAR |
| 2026-05-27 | 4 | CYTOKINETICS INC (CYTK) | Grant/award (A): 2,851 @ $0 · Grant/award (A): 4,301 (derivative) @ $0 | EDGAR |
| 2026-04-17 | 4 | IONIS PHARMACEUTICALS INC (IONS) | Sale (S): 4,466 @ $76.19 · Sale (S): 534 @ $76.97 | EDGAR |
| 2026-03-02 | 4 | CYTOKINETICS INC (CYTK) | Sale (S): 5,000 @ $61.21 | EDGAR |
| 2026-02-13 | 4 | IONIS PHARMACEUTICALS INC (IONS) | Sale (S): 5,000 @ $82.72 | EDGAR |
| 2025-11-19 | 4 | CYTOKINETICS INC (CYTK) | Sale (S): 5,000 @ $64.73 | EDGAR |
| 2025-10-16 | 4 | IONIS PHARMACEUTICALS INC (IONS) | Sale (S): 5,000 @ $71.74 | EDGAR |
| 2025-09-04 | 4 | IONIS PHARMACEUTICALS INC (IONS) | Sale (S): 10,750 @ $50.42 · Sale (S): 9,250 @ $51.49 | EDGAR |
| 2025-08-08 | 4 | IONIS PHARMACEUTICALS INC (IONS) | Sale (S): 4,600 @ $41.87 · Sale (S): 400 @ $42.63 | EDGAR |
| 2025-07-17 | 4 | IONIS PHARMACEUTICALS INC (IONS) | Option exercise (M): 4,079 @ $0 · Option exercise (M): 4,079 (derivative) @ $0 | EDGAR |
| 2025-07-02 | 4 | IONIS PHARMACEUTICALS INC (IONS) | Grant/award (A): 11,518 (derivative) @ $0 · Grant/award (A): 5,220 (derivative) @ $0 | EDGAR |
| 2025-06-17 | 4 | Foghorn Therapeutics Inc. (FHTX) | Grant/award (A): 25,000 (derivative) @ $4.79 | EDGAR |
| 2025-05-15 | 4 | CYTOKINETICS INC (CYTK) | Grant/award (A): 7,333 @ $0 · Grant/award (A): 10,880 (derivative) @ $0 | EDGAR |
| 2024-09-09 | 4 | CYTOKINETICS INC (CYTK) | Option exercise (M): 5,000 @ $21.61 · Sale (S): 5,000 @ $54.92 · Option exercise (M): 5,000 (derivative) @ $0 | EDGAR |
| 2024-08-26 | 4 | CYTOKINETICS INC (CYTK) | Option exercise (M): 5,000 @ $21.61 · Sale (S): 5,000 @ $57.26 · Option exercise (M): 5,000 (derivative) @ $0 | EDGAR |
| 2024-08-12 | 4 | CYTOKINETICS INC (CYTK) | Option exercise (M): 5,000 @ $21.61 · Sale (S): 5,000 @ $55.20 · Option exercise (M): 5,000 (derivative) @ $0 | EDGAR |
| 2024-07-31 | 4 | CYTOKINETICS INC (CYTK) | Option exercise (M): 5,000 @ $21.61 · Sale (S): 5,000 @ $59.84 · Option exercise (M): 5,000 (derivative) @ $0 | EDGAR |
| 2024-07-17 | 4 | IONIS PHARMACEUTICALS INC (IONS) | Option exercise (M): 4,677 @ $0 · Option exercise (M): 4,677 (derivative) @ $0 | EDGAR |
| 2024-07-16 | 4 | CYTOKINETICS INC (CYTK) | Option exercise (M): 5,000 @ $10.68 · Sale (S): 5,000 @ $55.82 · Option exercise (M): 5,000 (derivative) @ $0 | EDGAR |
| 2024-07-03 | 4 | IONIS PHARMACEUTICALS INC (IONS) | Grant/award (A): 10,111 (derivative) @ $0 · Grant/award (A): 4,079 (derivative) @ $0 | EDGAR |
| 2024-07-01 | 4 | CYTOKINETICS INC (CYTK) | Option exercise (M): 5,000 @ $10.68 · Sale (S): 5,000 @ $54.22 · Option exercise (M): 5,000 (derivative) @ $0 | EDGAR |
| 2024-06-28 | 4 | Foghorn Therapeutics Inc. (FHTX) | Grant/award (A): 16,000 (derivative) @ $5.52 | EDGAR |
| 2024-06-17 | 4 | CYTOKINETICS INC (CYTK) | Option exercise (M): 5,000 @ $10.68 · Sale (S): 5,000 @ $52.55 · Option exercise (M): 5,000 (derivative) @ $0 | EDGAR |
| 2024-06-04 | 4 | CYTOKINETICS INC (CYTK) | Option exercise (M): 5,000 @ $10.68 · Sale (S): 5,000 @ $48.64 · Option exercise (M): 5,000 (derivative) @ $0 | EDGAR |
| 2024-05-16 | 4 | CYTOKINETICS INC (CYTK) | Grant/award (A): 5,600 @ $0 · Grant/award (A): 3,636 (derivative) @ $0 | EDGAR |
| 2023-12-28 | 4 | IONIS PHARMACEUTICALS INC (IONS) | Option exercise (M): 25,113 @ $47.34 · Sale (S): 25,113 @ $51.46 · Option exercise (M): 50,000 @ $47.34 · Sale (S): 50,000 @ $50.23 · Option exercise (M): 42,525 @ $47.34 · Sale (S): 42,525 @ $50.19 · +3 more | EDGAR |
| 2023-09-28 | 4 | IONIS PHARMACEUTICALS INC (IONS) | Sale (S): 10,000 @ $45.13 | EDGAR |
| 2023-07-19 | 4 | IONIS PHARMACEUTICALS INC (IONS) | Option exercise (M): 1,777 @ $0 · Option exercise (M): 5,333 @ $0 · Option exercise (M): 1,777 (derivative) @ $0 · Option exercise (M): 5,333 (derivative) @ $0 | EDGAR |
| 2023-07-06 | 4 | IONIS PHARMACEUTICALS INC (IONS) | Grant/award (A): 10,321 (derivative) @ $0 · Grant/award (A): 4,677 (derivative) @ $0 | EDGAR |
| 2023-06-22 | 4 | Foghorn Therapeutics Inc. (FHTX) | Grant/award (A): 16,000 (derivative) @ $0 | EDGAR |
| 2023-05-18 | 4 | CYTOKINETICS INC (CYTK) | Grant/award (A): 5,000 @ $0 · Grant/award (A): 10,000 (derivative) @ $0 | EDGAR |
| 2022-09-01 | 4 | CYTOKINETICS INC (CYTK) | Option exercise (M): 5,714 @ $8.75 · Option exercise (M): 20,000 @ $9.45 · Option exercise (M): 4,582 @ $6.82 · Sale (S): 30,296 @ $52.79 · Option exercise (M): 5,714 (derivative) @ $0 · Option exercise (M): 20,000 (derivative) @ $0 · +1 more | EDGAR |
| 2022-08-18 | 4 | Foghorn Therapeutics Inc. (FHTX) | Grant/award (A): 32,000 (derivative) @ $16.34 | EDGAR |
| 2022-07-19 | 4 | IONIS PHARMACEUTICALS INC (IONS) | Option exercise (M): 5,333 @ $0 · Option exercise (M): 2,665 @ $0 · Option exercise (M): 5,333 (derivative) @ $0 · Option exercise (M): 2,665 (derivative) @ $0 | EDGAR |
| 2022-07-06 | 4 | IONIS PHARMACEUTICALS INC (IONS) | Grant/award (A): 12,000 (derivative) @ $0 · Grant/award (A): 5,333 (derivative) @ $0 | EDGAR |
| 2022-05-11 | 4 | CYTOKINETICS INC (CYTK) | Grant/award (A): 5,000 @ $0 · Grant/award (A): 10,000 (derivative) @ $0 | EDGAR |
| 2022-01-20 | 4 | IONIS PHARMACEUTICALS INC (IONS) | Option exercise (M): 5,754 @ $0 · Tax withholding (F): 1,652 @ $30.12 · Option exercise (M): 5,754 (derivative) @ $0 | EDGAR |
| 2021-11-05 | 4 | CYTOKINETICS INC (CYTK) | Option exercise (M): 20,000 @ $14.25 · Sale (S): 20,000 @ $40 · Option exercise (M): 4,032 @ $12.40 · Sale (S): 4,032 @ $40 · Option exercise (M): 4,166 @ $6.78 · Sale (S): 4,166 @ $40 · +6 more | EDGAR |
| 2021-10-20 | 4 | CYTOKINETICS INC (CYTK) | Option exercise (M): 1,999 @ $6.84 · Sale (S): 1,999 @ $35.73 · Option exercise (M): 8,333 @ $6.60 · Sale (S): 8,333 @ $35.73 · Option exercise (M): 8,333 (derivative) @ $0 · Option exercise (M): 1,999 (derivative) @ $0 | EDGAR |
| 2021-07-19 | 4 | IONIS PHARMACEUTICALS INC (IONS) | Option exercise (M): 5,333 @ $0 · Option exercise (M): 889 @ $0 · Option exercise (M): 1,778 @ $0 · Option exercise (M): 5,333 (derivative) @ $0 · Option exercise (M): 889 (derivative) @ $0 · Option exercise (M): 1,778 (derivative) @ $0 | EDGAR |
| 2021-07-06 | 4 | IONIS PHARMACEUTICALS INC (IONS) | Grant/award (A): 12,000 (derivative) @ $0 · Grant/award (A): 5,333 (derivative) @ $0 | EDGAR |
| 2021-05-13 | 4 | CYTOKINETICS INC (CYTK) | Grant/award (A): 5,000 @ $0 · Grant/award (A): 10,000 (derivative) @ $0 | EDGAR |
| 2021-01-20 | 4 | IONIS PHARMACEUTICALS INC (IONS) | Option exercise (M): 10,655 @ $0 · Tax withholding (F): 2,741 @ $61.28 · Option exercise (M): 10,655 (derivative) @ $0 | EDGAR |
| 2020-12-28 | 4 | IONIS PHARMACEUTICALS INC (IONS) | Sale (S): 10,000 @ $60 | EDGAR |
| 2020-11-30 | 4 | IONIS PHARMACEUTICALS INC (IONS) | Option exercise (M): 3,590 @ $39.87 · Sale (S): 3,590 @ $50.05 · Option exercise (M): 3,590 (derivative) @ $0 | EDGAR |
| 2020-11-25 | 4 | IONIS PHARMACEUTICALS INC (IONS) | Option exercise (M): 3,200 @ $39.87 · Sale (S): 3,200 @ $50.12 · Option exercise (M): 710 @ $39.87 · Sale (S): 710 @ $50.82 · Option exercise (M): 3,200 (derivative) @ $0 · Option exercise (M): 710 (derivative) @ $0 | EDGAR |
| 2020-10-13 | 4 | AKCEA THERAPEUTICS, INC. (AKCA) | Disposition to issuer (D): 26,400 (derivative) @ $2.01 | EDGAR |
FilingPulse's Form 4 archive currently extends back to 2020-10-05 and is expanding backward through EDGAR history; Forms 3 and 5 are covered live-forward since 2026-09-23 (no 3/5 history). Earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.
GET https://api.filingpulse.io/v1/insider-trades?owner_cik=1073385 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. Get a free API key → · API docs